Veronique Debien
0000-0003-1165-925X
Institut Jules Bordet
5 papers found
Refreshing results…
The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study
DECRESCENDO: de-escalating chemotherapy in HER2-positive, estrogen receptor-negative, node-negative early breast cancer
Optimizing treatment for HER2-positive HR-positive breast cancer
Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment
Immune response to anti-SARS-CoV-2 prime-vaccination in patients with cancer: a systematic review and meta-analysis
Missing publications? Search for publications with a matching author name.